FA
GILD icon

Fiduciary Alliance’s Gilead Sciences GILD Stock Holding History

Fiduciary Alliance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Sell
2,753
-19
-0.7% -$2.66K 0.02% 404
2025
Q4 		$340K Buy
2,772
+50
+2% +$6.08K 0.02% 403
2025
Q3 		$302K Buy
2,722
+162
+6% +$18.4K 0.02% 414
2025
Q2 		$284K Buy
+2,560
New +$272K 0.02% 400
2023
Q3 		– Sell
-75
Closed -$5.78K – 476
2023
Q2 		$5.78K Buy
+75
New +$5.98K ﹤0.01% 671
2023
Q1 		– Sell
-75
Closed -$6.44K – 420
2022
Q4 		$6.44K Buy
+75
New +$5.94K ﹤0.01% 481

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fiduciary Alliance's GILD Position: Q1 2026 in Review

Fiduciary Alliance reduced its Gilead Sciences (GILD) stake by 0.69% in Q1 2026, selling an estimated $2.66K and leaving 2,753 shares worth $385K. The position accounts for 0.02% of the portfolio, ranked #404.

Fiduciary Alliance first reported a position in GILD in Q4 2022 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fiduciary Alliance held 2,753 shares of Gilead Sciences worth $385K as of Q1 2026.
  • Fiduciary Alliance sold 19 Gilead Sciences shares in Q1 2026, an estimated $2.66K.
  • Gilead Sciences made up 0.02% of Fiduciary Alliance's portfolio in Q1 2026, its #404 holding.
  • Fiduciary Alliance first reported a position in Gilead Sciences in Q4 2022 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fiduciary Alliance's 13F filing for Q1 2026, filed 20 Apr 2026.